A mixing method cannot establish that a BPC-157 product has the intended identity, remains stable or is appropriate for human use. Preparation questions often begin with practical arithmetic, but the unresolved scientific problem comes earlier: what exactly is in the container, and what evidence characterizes that finished product?
Why the product matters
FDA's 2026 BPC-157 briefing distinguishes free-base and acetate materials and discusses missing or inadequate quality information. It also describes formulation-dependent concerns about peptide degradation and aggregation. These are reasons not to assume that a shared ingredient name makes different preparations equivalent.
This does not mean that an individual product has been proved contaminated. It means that a method or label alone does not demonstrate the properties needed to support its proposed use.
Separate the questions
Identity asks whether the intended molecule is present. Content asks how much is present. Purity asks what else accompanies it. Microbial quality and stability ask different questions again. A result addressing one property should not be presented as an answer to all of them.
Consider a certificate that reports only one analytical percentage. Without the method, sample traceability and scope of testing, that number cannot tell a reader everything about a finished preparation. This is an evidence-reading principle, not a judgment about a specific supplier.
Why a universal storage rule is inadequate
A storage claim is meaningful only for the formulation, container, conditions and period actually evaluated. Evidence for an unopened laboratory material cannot automatically establish the behavior of a different solution after handling.
The same limitation applies to appearance. A clear solution is not a comprehensive test of identity or quality, and a visual change cannot reveal its cause without investigation. Internet troubleshooting should not replace a pharmacist's assessment of a medicine or appropriate laboratory testing.
This article deliberately does not provide reconstitution instructions or a recipe. The central answer is that correct-looking preparation is not equivalent to a characterized medicinal product. Evidence about the molecule in a paper also cannot certify the contents of a catalog vial.